KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus’ natural ability to replicate in and kill cancer cells. This modality is known as oncolytic viral immunotherapy. KaliVir’s cutting-edge, next generation oncolytic viral immu...
Use this information to figure out if this company is an ideal customer for you.
412.435.6730
240 Alpha Drive
Pittsburgh, 15238
51 - 200 Employees
$50M - $100M
linkedin.com/company/kalivir-immunotherapeutics
KaliVir Immunotherapeutics's CEO is Helena Chaye
KaliVir Immunotherapeutics's CFO is Schond Greenway
KaliVir Immunotherapeutics's HQ is located at 240 Alpha Drive, Pittsburgh
KaliVir Immunotherapeutics's phone number is 412.435.6730
KaliVir Immunotherapeutics's official website is kalivir.com
KaliVir Immunotherapeutics's revenue is $50M - $100M
KaliVir Immunotherapeutics has 51 - 200 employees
KaliVir Immunotherapeutics is in the industry of: Pharmaceuticals
